A new study led by University of Michigan Comprehensive Cancer Center researchers shows the financial impact of cancer treatment. Four years after being treated for breast cancer, a quarter of survivors say they are worse off financially, at least partly because of their treatment. An additional 12% reported that they still have medical debt from their treatment.
The researchers found that financial decline varied significantly by race, with Spanish-speaking Latinas most…Continue
Added by Editorial Team on March 25, 2014 at 12:30pm — No Comments
A revolutionary breakthrough in the treatment of cancer could soon be underway following an important discovery which may lead to a dramatic improvement in cancer survival rates.
A new study published today in the International edition of Angewandte Chemie, reports how researchers at the University of Warwick have developed a new drug that can manipulate the body's natural signaling and energy systems, allowing the body to attack and shut down cancerous…Continue
Added by Editorial Team on March 25, 2014 at 10:00am — No Comments
Many cancer researchers believe that cutting-edge advances in genomics will pave the way for "personalized" or "precision" cancer medicine for all patients in the near future. A new study by researchers at Dana-Farber Cancer Institute, however, suggest that not all doctors are ready to embrace tests that look for hundreds of DNA changes in patients' tumor samples, while others plan to offer this type of cancer gene testing to most of their patients. The findings are published in the…Continue
Added by Editorial Team on March 24, 2014 at 2:00pm — No Comments
Prostate cancer is second leading cause of cancer death in Western world. Each year, around the world, over 670,000 men are diagnosed with the disease. In the United States, there were 238,590 new cases of prostate cancer in 2013. Nearly 30,000 men died of the disease in the U.S. in that year. Now a study published online in Journal of the National Cancer Institute by researchers from Umeå University, Sweden and…Continue
Added by Editorial Team on March 10, 2014 at 11:30am — No Comments
By Brianza Nyborg (Contributing Author)
A new market research report published earlier this year by Reportlinker.com discusses the increased importance of targeted therapies in the treatment of patients with cancer. The report describes how changes the availability of thearpies is expected to influence…Continue
Added by Editorial Team on March 3, 2014 at 10:00pm — No Comments
It is not only genetics that predispose to bowel cancer. According to new research in mice published in the March 3, 2014 issue of JEM/The Journal of Experimental Medicine, microbes living in the gut help drive the development of intestinal tumors.
Bowel cancer, also called colon or colorectal cancer, is the third most common non-skin cancer and the second leading cause of cancer-related mortality in men and women in the United States. The available data shows that over the…Continue
Added by Editorial Team on March 3, 2014 at 1:30pm — No Comments
The randomized Phase II multi-center PALOMA-1 trial of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) for the combination of palbociclib (125 mg once daily for three out of four weeks in repeated cycles) and letrozole compared with letrozole alone (2.5 mg once daily on a continuous regimen) in post-menopausal women with estrogen receptor positive (ER+), human…Continue
Added by Editorial Team on March 3, 2014 at 12:30am — No Comments